Jove
Visualize
Contact Us

Related Experiment Videos

Cardiovascular proteomics: past, present, and future.

Melanie Y White1, Jennifer E Van Eyk

  • 1Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224, USA.

Molecular Diagnosis & Therapy
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same author

Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives.

Journal of translational internal medicine·2026
Same author

Consensus statement on mass spectrometry-based proteomic analysis of cardiac tissue.

Nature cardiovascular research·2026
Same author

Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences.

European heart journal·2026
Same author

A Targeted LC-MS/MS Assay of a Health Surveillance Panel and Its Application to Chronic Kidney Disease.

Journal of proteome research·2026
Same author

Capturing Cardiomyocyte Cell-to-Cell Heterogeneity via Shotgun Single Cell Top-Down Proteomics.

bioRxiv : the preprint server for biology·2026
Same journal

Multiplex RT-PCR-Based Sequencing Assay to Detect Kidney Cancer-Specific Splice Variants in Tumor Tissues and Plasma Cell-Free RNAs.

Molecular diagnosis & therapy·2026
Same journal

Individualized Longitudinal ctDNA Monitoring in Melanoma Using Multiplexed USE-PCR.

Molecular diagnosis & therapy·2026
Same journal

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Molecular diagnosis & therapy·2026
Same journal

Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer.

Molecular diagnosis & therapy·2026
Same journal

Tividenofusp Alfa: First Approval.

Molecular diagnosis & therapy·2026
Same journal

Genetics of Cerebrotendinous Xanthomatosis.

Molecular diagnosis & therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Proteomics reveals molecular changes in cardiovascular diseases like dilated cardiomyopathy and atherosclerosis. This technology aids in identifying potential biomarkers and therapeutic targets for better diagnosis and treatment of heart conditions.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Proteomics

Background:

  • Cardiovascular diseases are a leading cause of global mortality, impacting quality of life and healthcare economics.
  • Understanding cellular and molecular alterations is crucial for managing cardiovascular pathologies.
  • Proteomics offers advanced tools to investigate the protein complement, influencing cellular phenotype and disease progression.

Purpose of the Study:

  • To explore the application of proteomics in understanding cardiovascular diseases.
  • To identify novel protein biomarkers and therapeutic targets for cardiovascular conditions.
  • To bridge basic science discoveries with clinical applications in cardiovascular medicine.

Main Methods:

  • Proteomic investigations applied to cardiovascular diseases such as dilated cardiomyopathy, atherosclerosis, and ischemia/reperfusion injury.

Related Experiment Videos

  • Analysis of complex protein mixtures using multi-dimensional separation techniques based on protein properties (charge, mass, hydrophobicity, location).
  • Examination of protein alterations in both tissues/cells and biological fluids (biofluids).

    • Main Results:

    • Identified candidate proteins altered in pathological cardiovascular states, complementing existing data.
    • Observed alterations in myofilament proteins (e.g., troponin I, myosin light chain) correlating with reduced myocardial contractility in dilated cardiomyopathy and ischemia/reperfusion.
    • Investigated diverse cell types in atherosclerosis and changes in biofluids associated with cardiovascular pathologies.

    Conclusions:

    • Proteomics is emerging as a vital technique for cardiovascular disease research.
    • Proteomic findings provide potential biomarkers for early detection and screening in tissues and biofluids.
    • This approach holds promise for more effective diagnosis and treatment strategies for cardiovascular diseases.